WallStreetZenWallStreetZen

NASDAQ: MNMD
Mind Medicine Inc Stock Forecast, Predictions & Price Target

Analyst price target for MNMD

Based on 2 analysts offering 12 month price targets for Mind Medicine Inc.
Min Forecast
$7.00+51.52%
Avg Forecast
$7.00+51.52%
Max Forecast
$7.00+51.52%

Should I buy or sell MNMD stock?

Based on 2 analysts offering ratings for Mind Medicine Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MNMD stock forecasts and price targets.

MNMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-10-23
lockedlocked$00.00+00.00%2023-08-22

1 of 1

Forecast return on equity

Is MNMD forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
24.42%

Forecast return on assets

Is MNMD forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

MNMD revenue forecast

What is MNMD's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$85.0M
Avg 2 year Forecast
$349.5M
Avg 3 year Forecast
$757.1M

MNMD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MNMD$4.62$7.00+51.52%Strong Buy
LCTX$1.06$6.50+513.21%Strong Buy
ATNM$6.66$25.87+288.39%Strong Buy
INO$7.89$8.00+1.39%Buy
GNFT$3.59$11.00+206.41%Buy

Mind Medicine Stock Forecast FAQ

Is Mind Medicine Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: MNMD) stock is to Strong Buy MNMD stock.

Out of 2 analysts, 1 (50%) are recommending MNMD as a Strong Buy, 1 (50%) are recommending MNMD as a Buy, 0 (0%) are recommending MNMD as a Hold, 0 (0%) are recommending MNMD as a Sell, and 0 (0%) are recommending MNMD as a Strong Sell.

If you're new to stock investing, here's how to buy Mind Medicine stock.

What is MNMD's revenue growth forecast for 2026-2028?

(NASDAQ: MNMD) Mind Medicine's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 48.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.9%.

Mind Medicine's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast MNMD's revenue for 2026 to be $3,407,448,759, with the lowest MNMD revenue forecast at $809,913,102, and the highest MNMD revenue forecast at $6,004,984,417. On average, 2 Wall Street analysts forecast MNMD's revenue for 2027 to be $14,011,296,184, with the lowest MNMD revenue forecast at $8,223,424,611, and the highest MNMD revenue forecast at $19,799,167,757.

In 2028, MNMD is forecast to generate $30,355,703,427 in revenue, with the lowest revenue forecast at $18,166,912,195 and the highest revenue forecast at $42,544,494,659.

What is MNMD's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: MNMD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is MNMD's Price Target?

According to 2 Wall Street analysts that have issued a 1 year MNMD price target, the average MNMD price target is $7.00, with the highest MNMD stock price forecast at $7.00 and the lowest MNMD stock price forecast at $7.00.

On average, Wall Street analysts predict that Mind Medicine's share price could reach $7.00 by Oct 23, 2024. The average Mind Medicine stock price prediction forecasts a potential upside of 51.52% from the current MNMD share price of $4.62.

What is MNMD's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: MNMD) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.